AstraZeneca Under Scrutiny Again as Countries Spend Billions on Questionable Vaccine
Thanks to Maxwell for providing us with this article... AstraZeneca Under Scrutiny Again as Countries Spend Billions on Questionable Vaccine Another AstraZeneca vaccine trial participant alleges serious injury, but the vaccine is still a favorite with the Gates Foundation and developing countries. By Jeremy Loffredo AstraZeneca’s COVID vaccine faced new controversy this week after a trial participant in India alleged that the vaccine caused him serious “neurological and psychological” symptoms. The accusation was the latest in a series of complaints or concerns surrounding Covishield, the AstraZeneca vaccine being developed in partnership with Oxford University. Yet despite concerns about safety and trial design, countries are already spending billions of dollars in taxpayer funds to purchase AstraZeneca’s vaccine, in part because, compared with frontrunners Moderna and Pfizer , AstraZeneca’s vaccine is easier to s...